Therapeutic inhibitors targeting ER stress response sensitize tumor cells to GLUT inhibitors‐induced disulfidptosis and dramatically suppress tumor growth, conceptualizing combined therapy by targeting disulfidptosis in cancer treatments. This evidence concerns the gene SLC2A1 and neoplasm.